tradmap

CL Financials Colgate-Palmolive

15 years of revenue, profit, cash flow and balance-sheet history through FY2025, from SEC filings — with a computed, factual read of the trend. Updated Overview →

Growth & profitability

  • Revenue has grown 4.4% per year over the past 5 years.
  • Net income has grown slower than revenue (-4.6% vs 4.4% per year).
  • Operating margin has contracted, at 16.2% in the latest year.
  • Free cash flow has grown 1.9% per year over the past 5 years.

Financial health

  • Total debt ($7.8B) exceeds cash ($1.3B); net debt is $6.6B.
  • Total debt has grown slower than revenue (1.3% vs 4.4% per year).
  • Operating income covered interest expense 12× in the latest year.
  • Total debt is 2.0× EBITDA.
Revenue & net income
$0 $10B $20B 2011 2013 2015 2017 2019 2021 2023 2025
RevenueNet income
Margins (gross / operating / net)
0% 30% 61% 2011 2013 2015 2017 2019 2021 2023 2025
GrossOperatingNet
Free cash flow (CFO − capex)
$0 $2B $4B 2011 2013 2015 2017 2019 2021 2023 2025
Free cash flow
Cash vs total debt
$0 $4B $9B 2011 2013 2015 2017 2019 2021 2023 2025
CashTotal debt
Cash flow: operating / investing / financing
-$3B $405M $4B $0 2011 2013 2015 2017 2019 2021 2023 2025
OperatingInvestingFinancing

Key annual figures

FYRevenueNet incomeGross MOp MFCFTotal debtCash
2025 $20.4B $2.1B 60.1% 16.2% $3.6B $7.8B $1.3B
2024 $20.1B $2.9B 60.5% 21.2% $3.5B $7.0B $1.1B
2023 $19.5B $2.3B 58.2% 20.5% $3.0B $8.2B $966M
2022 $18.0B $1.8B 57.0% 16.1% $1.9B $8.8B $775M
2021 $17.4B $2.2B 59.6% 19.1% $2.8B $7.2B $832M
2020 $16.5B $2.7B 60.8% 23.6% $3.3B $7.3B $888M
2019 $15.7B $2.4B 59.4% 22.6% $2.8B $7.6B $883M
2018 $15.5B $2.4B 59.4% 23.8% $2.6B $6.4B $726M
2017 $15.5B $2.0B 60.0% 24.0% $2.5B $6.6B $1.5B
2016 $15.2B $2.4B 60.0% 26.0% $2.5B $6.5B $1.3B
2015 — $1.4B — — $2.3B $6.5B $970M
2014 — $2.2B — — $2.5B $6.1B $1.1B
2013 — $2.2B — — $2.5B $5.6B $962M
2012 — $2.5B — — $2.6B $5.2B $884M
2011 — $2.4B — — $2.4B $4.8B $878M

Valuation over time

How the market has priced CL against its own fundamentals since 2023-03 — each month-end's share price set against the most recent annual filing, so the multiple moves as price runs ahead of (or behind) earnings. Split-adjusted.

Price / earnings (P/E)
0.0 18.6 37.2 Mar '23 Aug '23 Jan '24 Jun '24 Nov '24 Apr '25 Sep '25 Feb '26
P/E
Price / sales (P/S)
0.0 2.2 4.4 Mar '23 Aug '23 Jan '24 Jun '24 Nov '24 Apr '25 Sep '25 Feb '26
P/S

Frequently asked questions

Is CL growing its revenue and profit?

Over the past 5 years, Colgate-Palmolive's revenue has grown 4.4% per year, and net income declined 4.6% per year. These are computed facts, not advice.

How much debt does CL have?

As of FY2025, Colgate-Palmolive reported $7.8B of total debt against $1.3B of cash; operating income covered interest expense 12×.

What is CL's profit margin?

In FY2025, gross margin was 60.1%, operating margin 16.2%, and net margin 10.5%.

What is CL's P/E ratio?

As of Jun '26, Colgate-Palmolive traded at a price-to-earnings ratio of about 34.2× (market cap ÷ latest annual net income). The valuation charts above show how its P/E, P/S have moved with the share price. These are computed facts, not advice.

Where does this data come from?

All figures are extracted from the company’s SEC EDGAR/XBRL filings — 10-K annual reports and 10-Q quarterly reports (use the Annual / Quarterly toggle). Quarterly figures are derived from the as-filed statements (year-to-date amounts are differenced into discrete quarters). Growth rates and ratios are computed by tradmap; nothing here is investment advice.

Source: SEC EDGAR / XBRL (10-K + 10-Q filings) · prices EOD (Databento), corporate-action-adjusted · growth rates, valuation multiples & ratios computed by tradmap. Valuation uses each month-end price against the latest annual filing. Informational only — not investment advice.